ArticleJournal of medicinal chemistry2020

Novel Human Neutral Sphingomyelinase 2 Inhibitors as Potential Therapeutics for Alzheimer's Disease.

Michal Šála et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.